| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
PerkinElmer Inc (NYSE: PKI)
PKI Technical Analysis
5
| As on 9th Jun 2023 PKI SHARE Price closed @ 111.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 154.23 & Strong Sell for SHORT-TERM with Stoploss of 182.02 we also expect STOCK to react on Following IMPORTANT LEVELS. |
PKISHARE Price
| Open | 112.00 | Change | Price | % |
| High | 113.00 | 1 Day | -0.36 | -0.32 |
| Low | 110.75 | 1 Week | -5.36 | -4.60 |
| Close | 111.09 | 1 Month | -23.77 | -17.63 |
| Volume | 605284 | 1 Year | -76.68 | -40.84 |
| 52 Week High 201.06 | 52 Week Low 114.21 | ||||
NYSE USA Most Active Stocks
| DDR | 15.44 | -4.46% |
| NIO | 7.73 | -0.77% |
| TWTR | 53.70 | 0.66% |
| CVNA | 19.07 | -21.30% |
| BACA-U | 302.00 | 0.67% |
| PLTR | 15.02 | -1.12% |
| F | 13.74 | 1.18% |
| CS | 0.89 | 1.14% |
| RPAI | 13.15 | -3.17% |
| AUY | 5.85 | -0.68% |
NYSE USA Top Gainers Stocks
NYSE USA Top Losers Stocks
| PKI Daily Charts |
PKI Intraday Charts |
Whats New @ Bazaartrend |
PKI Free Analysis |
|
|
PKI Important Levels Intraday
| RESISTANCE | 115.43 |
| RESISTANCE | 114.04 |
| RESISTANCE | 113.18 |
| RESISTANCE | 112.32 |
| SUPPORT | 109.86 |
| SUPPORT | 109.00 |
| SUPPORT | 108.14 |
| SUPPORT | 106.75 |
PKI Forecast April 2024
| 4th UP Forecast | 165.74 |
| 3rd UP Forecast | 148.21 |
| 2nd UP Forecast | 137.38 |
| 1st UP Forecast | 126.55 |
| 1st DOWN Forecast | 95.63 |
| 2nd DOWN Forecast | 84.8 |
| 3rd DOWN Forecast | 73.97 |
| 4th DOWN Forecast | 56.44 |
PKI Weekly Forecast
| 4th UP Forecast | 138.11 |
| 3rd UP Forecast | 129.44 |
| 2nd UP Forecast | 124.09 |
| 1st UP Forecast | 118.73 |
| 1st DOWN Forecast | 103.45 |
| 2nd DOWN Forecast | 98.09 |
| 3rd DOWN Forecast | 92.74 |
| 4th DOWN Forecast | 84.07 |
PKI Forecast2024
| 4th UP Forecast | 289.16 |
| 3rd UP Forecast | 232.05 |
| 2nd UP Forecast | 196.75 |
| 1st UP Forecast | 161.45 |
| 1st DOWN Forecast | 60.73 |
| 2nd DOWN Forecast | 25.43 |
| 3rd DOWN Forecast | -9.87 |
| 4th DOWN Forecast | -66.98 |
PerkinElmer Inc ( NYSE USA Symbol : PKI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
PKI Business Profile
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. Address: 940 Winter Street, Waltham, MA, United States, 02451
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service